Clinical Trials · NCT03648281
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Denmark and Sweden, as Part of Local Clinical Practice (SURE DENMARK/SWEDEN)
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 333
- Start date
- Aug 2018
- Locations
- 30 sites, Denmark, Sweden
- Primary endpoint
- Change in Glycated Haemoglobin A1c (HbA1c)